Young Teresa L. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Young Teresa L.（CIK 1814656）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-02-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 231 | $0 |
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 卖出 | 75 | $635 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 3,998 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 132 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 98 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 卖出 | 1,042 | $18,027 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 133 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 97 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 卖出 | 59 | $982 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 133 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 买入 | 98 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Commercial & Strategy Officer | 卖出 | 63 | $459 |
来源：SEC Form 4 申报文件 · 截至 2026-02-18